Alpha Tau Medical Ltd.
DRTS
$14.46
-$0.38-2.56%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 47.00% | 10.40% | 20.48% | 8.20% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 42.85% | 22.66% | 6.56% | 10.49% | |
| Operating Income | -42.85% | -22.66% | -6.56% | -10.49% | |
| Income Before Tax | -353.62% | -28.47% | -36.42% | -7.67% | |
| Income Tax Expenses | 252.31% | -1,850.00% | 2,066.67% | 9,800.00% | |
| Earnings from Continuing Operations | -352.97% | -28.07% | -37.25% | -8.90% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -352.97% | -28.07% | -37.25% | -8.90% | |
| EBIT | -42.85% | -22.66% | -6.56% | -10.49% | |
| EBITDA | -41.75% | -22.96% | -6.92% | -10.75% | |
| EPS Basic | -300.72% | -4.29% | -19.15% | -7.77% | |
| Normalized Basic EPS | -301.02% | -4.62% | -18.51% | -- | |
| EPS Diluted | -300.72% | -4.29% | -19.15% | -7.77% | |
| Normalized Diluted EPS | -301.02% | -4.62% | -18.51% | -- | |
| Average Basic Shares Outstanding | 13.05% | 22.85% | 15.15% | 1.06% | |
| Average Diluted Shares Outstanding | 13.05% | 22.85% | 15.15% | 1.06% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |